NCT05570448招募中不适用
Anti-Reflux Endoscopic Therapy Using Argon Plasma Coagulation (AREA) in Gastroesophageal Reflux Disease (GERD) Patients: A Single Center, Randomized, Sham, Controlled Trial (The AREA Study)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 36
- 试验地点
- 2
- 主要终点
- Change in GERD health related quality of life (GERD-HRQL) score
研究概览
简要总结
This will be a randomized clinical trial examining the efficacy and safety of ARAT (intervention group) in patients with chronic GERD symptoms (typical symptoms of GERD, i.e. heartburn or acid reflux/regurgitation at least twice a week) for the last 6 months.
Patients must have a positive pH test and a negative manometry (no treatment) procedure.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Care Provider)
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Chronic GERD symptoms (at least 1 typical symptom of GERD, i.e. heartburn or acid reflux/regurgitation at least twice a week) for last 6 months
- •Objective evidence of reflux disease (positive ambulatory pH study.)
排除标准
- •Patients unable to or unwilling to participate or consent.
- •Age <18 years or >80 years.
- •Allergic or intolerant to PPI medications.
- •Large hiatal hernia > 3 cm and Hill grade IV.
- •Barrett's esophagus.
- •Esophageal stricture with any prior intervention.
- •Major motility disorder.
- •Eosinophilic esophagitis.
- •Gastroparesis documented by abnormal gastric emptying time.
- •Previous fundoplication, myotomy or LINX surgery.
- •Cirrhosis with esophageal and/or gastric varices.
结局指标
主要结局
Change in GERD health related quality of life (GERD-HRQL) score
时间窗: At 3, 6 and 12 months
The primary outcome of quality of life will be measured using the validated GERD related quality of life questionnaire (GERD-HRQL). The total score is 50, and a higher score is associated with more severe symptoms.
次要结局
- Acid exposure time (AET)(At 3 and 12 months)
- Esophagitis incidence(At 3 and 12 months)
- Change in Reflux disease questionnaire (RDQ) score(At 3, 6 and 12 months)
- Change in Proton pump inhibitor (PPI) use(At 3, 6 and 12 months)
- Adverse events(Post-randomization (Day 1, Day 30, 3rd, 6th and 12th month))
- Change in Hiatal hernia grading(At 3 and 12 months)
研究者
研究点 (2)
Loading locations...
相似试验
Unknown
不适用
ARMA for Postoperative GERD After Sleeve GastrectomyGastroesophageal RefluxNCT05259579Chinese University of Hong Kong15
招募中
不适用
Anti-Reflux Endoscopic Therapy Using Argon Plasma Coagulation (AREA) in Gastroesophageal Reflux Disease (GERD) Patients: A Single Center, Randomized, Sham, Controlled Trial (The AREA Study)GERDNCT06641375Asian Institute of Gastroenterology, India18
尚未招募
不适用
Anti-reflux Mucosal Ablation Therapy Randomized Sham Control Trial for Gastroesophageal Reflux DiseaseGastroesophageal Reflux DiseaseNCT06106100Far Eastern Memorial Hospital68
已完成
不适用
Hybrid Argon Plasma Coagulation and Endoscopic Sleeve Gastroplasty TrialObesityNCT05559866Mayo Clinic45
已完成
不适用
ANTI REFLUX MUCOSAL ABLATION THERAPHY (ARMA)GERDNCT04243668Asian Institute of Gastroenterology, India216